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Despite the fact that Esenbeckia leiocarpa, a Brazilian plant, possesses potential anti-inﬂammatory properties, its eﬀect in
neutrophils, key players in inﬂammation, has never been investigated. In this study, a crude hydroalcoholic extract (CHE) was
used to evaluate the potential toxic or agonistic eﬀect of E. leiocarpa in human neutrophils. At a noncytotoxic concentration
of 500μg/mL, CHE increased actin polymerization and cell signaling events, especially p38 MAPK. Its modulatory activity on
neutrophil cell apoptosis was investigated by cytology and by ﬂow cytometry and, although CHE increased the apoptotic rate (by
cytology) and increased annexin-V binding, it did not, unexpectedly, increase CD16 shedding. CHE increased the degradation of
the cytoskeletal proteins gelsolin and paxillin but, surprisingly, not of vimentin. The proapoptotic activity of CHE was reversed
by a pan-caspase inhibitor but not by a p38 inhibitor. We conclude that CHE is a novel human neutrophil agonist that induces
apoptosis by a caspase-dependent and p38-independent mechanism in an atypical fashion based on its lack of eﬀect on CD16
shedding and vimentin degradation. Since the resolution of inﬂammation occurs by elimination of apoptotic neutrophils, the
ability of CHE to induce neutrophil apoptosis correlates well with its anti-inﬂammatory properties, as previously reported.
1.Introduction
Brazil boasts the greatest plant diversity on the world
(approximately55,000speciesofhigherplants)[1].Brazilian
plants represent a large source of potentially therapeutic
compounds, a variety of which have been used in attempts
to treat several infectious and/or inﬂammatory conditions.
Esenbeckia species, such as Esenbeckia leiocarpa (Rutaceae),
are wide spread in several Brazilian regions. The presence
of various chemical constituents, primarily alkaloids, has
already been demonstrated in this genus [2, 3]. In addition,
coumarins [4], chalcones [4], as well as triterpenes and
lignanshavebeenshowntobe,atleastinpart,responsiblefor
diﬀerent biological properties already attributed to this herb,
including antimalarial [5], antiparasitic [6], antimicrobial
[7], and anticholinesterasic [2]e ﬀects.
Therearefewstudiesinvestigatingtheanti-inﬂammatory
eﬀectofEsenbeckialeiocarpa.H o wev er ,previousreportsha v e
singledoutalkaloidsasplayingapivotalroleininﬂammatory
conditions. For instance, Jiao et al. [8] showed that some
alkaloids promote a potent inhibitory activity on the pro-
duction of nitric oxide (NO), tumor necrosis factor α (TNF-
α), or interleukin 6 (IL-6), in mouse macrophage RAW264.7
cells stimulated by lipopolysaccharide (LPS) [8]. Others
have demonstrated that the alkaloid 6-ethoxybuphanidrine
was eﬀective in inducing apoptosis in HL-60 and MDA-
MB-231 tumor cell lines [9]. Other chemical constituents
have caused antiproliferative and pro-apoptotic eﬀects.
Coumarins induced apoptosis in HeLa cells through a ROS-
mediated mitochondrial dysfunction pathway. Moreover,
chalcones were eﬀective in inducing early apoptosis in HL60
cells [10, 11]. Recently, Esenbeckia leiocarpa was found to2 Mediators of Inﬂammation
possess interesting anti-inﬂammatory activity in vivo since it
protected against carrageenan-induced inﬂammation [12].
Polymorphonuclear neutrophil cells (PMNs) are known
for their major role in inﬂammation. These cells are the ﬁrst
to arrive at inﬂammatory sites, where they secrete diﬀerent
cytokines/chemokines that attract either other PMNs or
other leukocytes [13–15]. Because the resolution of inﬂam-
mation is known to occur by the elimination of apoptotic
PMNs by professional phagocytes, it is important to identify
new agents that can induce or accelerate PMN apoptosis,
sincesuchagentscouldrepresentfuturepotentialtherapeutic
candidates [14–18]. In order to investigate the potential
anti-inﬂammatory properties of Esenbeckia leiocarpa and to
better understand the mode of action involved, we decided
to determine whether or not a crude extract preparation
of this plant could activate human PMNs and if it can
accelerate their ability to undergo spontaneous apoptosis
(SA). We found that the crude hydroalcoholic extract (CHE)
of Esenbeckia leiocarpa bark can activate human PMNs by
inducing actin polymerization, cell signaling events, and
cleavage of some cytoskeletal proteins. Also, we demonstrate
that CHE accelerates SA by a mechanism involving caspases
but not p38 activation but also by a mechanism that does not
increase vimentin cleavage and CD16 shedding.
2.MaterialsandMethods
2.1. Plant Materials. Samples of bark from Esenbeckia
leiocarpa were collected in Aren´ apolis, a town located in
the state of Mato Grosso, Brazil, collected in August 2007
and were identiﬁed by a biologist, Professor Dr. Celice
Alexandre, of the State University of Mato Grosso, Tangar´ a
da Serra, MT, Brazil, where a voucher specimen (38639)
was deposited. Esenbeckia leiocarpa barks were air-dried and
protected from light at room temperature (25◦C) for one
week. In addition, the dried barks (5400g) were ground into
particles (1.5mm) using a knife mill (Mill TE-651, Tecnal,
Piracicaba, SP, Brazil). The ground material was extracted
with 8 L of 96% ethanol (plant material: ethanol 1:8, w/v) at
room temperature. After ten days, the extract obtained was
ﬁltered (using Whatman paper no. 1), and the ethanol was
removed by rotavapor (Fisatom-802, S˜ ao Paulo, SP, Brazil)
at 55◦C under reduced pressure (460mmHg; Vacuum Q-
355A2, Quimis, Diadema, SP, Brazil). In order to obtain a
ﬁnal lyophilized powder, this procedure was repeated three
times in a period of one month, with a resulting yield of
290g to the crude hydroalcoholic extract (CHE). CHE was
dissolved in the diluent composed of HBSS-1% dimethyl
sulfoxide (DMSO) (Sigma Chemical Company (St. Louis,
MO, USA)).
2.2. Chemical and Agonists. The plant lectin Viscum album
agglutinin 1 (VAA-I) used as an inducer of PMN apoptosis
[19], dimethyl sulfoxide (DMSO), SB203580, a speciﬁc
cell-permeable inhibitor of the MAP kinase homologues
p38alpha, p38beta, and p38beta2, and PD98059, an
inhibitor of MEK1 and MEK2, two enzymes leading to
phosphorylation of ERK-1/2 and N-formyl-methionyl-
leucyl-phenylalanine (fMLP), were purchased from Sigma
Chemical Company (St. Louis, MO, USA). The FITC-
phalloidin conjugate was purchased from Molecular Probes
(Eugene, OR, USA). FITC-Annexin-V was purchased from
BioSource International (Camarillo, CA, USA) and FITC-
mouse anti-human CD16 mAb was purchased from BD
Pharmingen (Mississauga, Ontario, Canada). Granulocyte
macrophage colony-stimulating factor (GM-CSF), a classical
PMN agonist and antiapoptotic agent, was purchased from
PeproTech Inc (Rocky Hill, NJ, USA). The caspase-1, -3, -4,
and -7 inhibitor N-benzyloxycarbonyl-V-A-D-O-methyl-
ﬂuoromethylketone(z-VAD-FMK)waspurchasedfromCal-
biochem (La Jolla, CA). The caspase-3 inhibitor z-Asp
(OMe)-Gln-Met-Asp(OMe)-FMK (z-DQMD-FMK), the ir-
reversible caspase-6 inhibitor z-Val-Glu(OMe)-Ile-Asp
(OMe)-FMK (z-VEID-FMK), and the irreversible caspase-9
inhibitor z-Leu-Glu(OMe)-His-Asp(OMe)-FMK (z-LEHD-
FMK) were purchased from Calbiochem (La Jolla, CA).
The following mAbs to human cytoskeletal proteins were
purchased from Sigma-Aldrich (St. Louis, MO): anti-
gelsolin (clone GS-2C4), anti-paxillin (clone PXC-10), and
anti-vimentin (clone V9).
2.3. Neutrophil Isolation. Cells were isolated from venous
blood of healthy volunteers by dextran sedimentation fol-
lowed by centrifugation over Ficoll-Hypaque (Amersham
Pharmacia Biotech Inc., Baie d’Urf´ e, Qu´ ebec, Canada), as
described previously [20]. Blood donations were obtained
from informed and consenting individuals according to our
institutionally approved procedures. Cell viability (>98%)
was monitored by Trypan blue exclusion, and the purity
(>98%)wasveriﬁedbycytologyfromcytocentrifugedprepa-
rations stained using the Hema-3 stain set (Biochemical
Sciences Inc., Swedesboro, NJ, USA), according to the manu-
facturer’s protocol.
2.4. Actin Polymerization. Freshly isolated human neu-
trophils (10 × 106 cells/mL suspended in RPMI-1640) were
incubated for short periods of time (5, 15 or 30min.) at
37◦Cwi t hb u ﬀer (DMSO 1%) or CHE (500μg/mL) in a ﬁnal
volume of 100μL. Synthetic peptide N-formyl-methionyl-
leucyl-phenylalanine (fMLP) (a classical neutrophil activa-
tor) at the dose of 10−8M was used as positive control.
After incubation of PMNs with buﬀer or CHE, digitonin and
paraformaldehyde (PFA) were used for permeabilization and
cell ﬁxation, respectively. Cells were washed and incubated
with phalloidin-FITC (binds to ﬁlamentous of actin) for
20min at 4◦C (light protected) prior to FACS analysis. Flow
cytometric analysis (10,000 events) was performed using a
FACScan (BD Biosciences, Sao Jose, CA, USA).
2.5. Tyrosine Phosphorylation Events. Neutrophils (10 × 106
cells/mL in RPMI-1640) were incubated for 0.5, 1, 5, 15, 30,
45, or 60min at 37◦C with the diluent (HBSS-1%DMSO),
GM-CSF (65ng/mL), or CHE (500μg/mL) in a ﬁnal volume
of 100μL. Reactions were stopped by adding 35μLo fa4 X
Laemmli sample buﬀer. Aliquots corresponding to 1 × 106Mediators of Inﬂammation 3
cells were loaded onto 10% SDS-PAGE and transferred from
gel to nitrocellulose membranes (Amersham Pharmacia Bio-
tech Inc., Baie d’Urf´ e, Qu´ ebec, Canada). Nonspeciﬁc sites
were blocked with 3% bovine serum albumin (BSA) in
TBS-Tween (25mM Tris-HCl, pH 7.8, 190mM NaCl, 0.15%
T w e e n - 2 0 )f o r1 ha tr o o mt e m p e r a t u r e .T h em o n o c l o n a l
antiphosphotyrosine (clone 4G10 (1:1000)) was then incu-
b a t e dw i t hm e m b r a n e sf o r1ha t3 7 ◦C followed by washes
and incubated with a horseradish peroxidase-labelled goat
anti-mouse IgG (1:15,000, Bio/Can) for 1h at room tem-
peraturein fresh blocking solution. Membranes were washed
three times with TBS-Tween, and phosphotyrosine bands
were revealed with the enhanced chemiluminescence (ECL)
Western blotting detection system (Amersham Pharmacia
Biotech Baie d’Urf´ e, Qu´ ebec, Canada). Protein loading was
veriﬁed by staining the membranes with Coomassie blue at
the end of the experiments.
2.6. Activation of p38 and ERK-1/2. Neutrophils (10 ×
106 cells/mL) were isolated and incubated as above at 37◦C
with buﬀer (DMSO 1%) or CHE (500μg/mL) in a ﬁnal
volume of 100μL. Reactions were stopped by adding 35μL
4X Laemmeli’s sample buﬀer, as described previously [21].
Samples corresponding to 1 × 106 c e l l sw e r el o a d e do n t o
10% SDS-PAGE and transferred from gel to nitrocellulose
membranes (Amersham Pharmacia Bio-tech Inc.). Nonspe-
ciﬁc sites were blocked with 3% bovine serum albumin
(BSA) in TBS-Tween (25mM Tris-HCl, pH 7.8, 190mM
NaCl, 0.15% Tween-20) and Western blots were performed
as described previously by Pelletier et al., in 2002 [21]. Mon-
oclonal antiphospho-p38 (pTpY180/182) antibody (1:1000;
Biosource, Camarillo, CA, USA) and HRP-conjugated goat
anti-mouse(1:15,000),ormonoclonalanti-phosphospeciﬁc
ERK-1/2 MAPK (clone 12D4) (Upstate cell signalling, Lake
Placid,NY,USA)andHRP-goatanti-rabbit(1:15,000),both
diluted in 3% nonfat dry milk, were used. Membranes were
strippedfor30minat55◦Cwithstrippingbuﬀer(100mM2-
ME, 2% SDS, 62.5mM Tris, pH 6.7), washed, and reprobed
with an anti-p38 (clone C-20: sc-535) (1:1000; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), or polyclonal
anti-ERK-1/2 (Millipore, Billerica, MA, USA) antibodies
followed by an HRP-conjugated goat anti-mouse IgG + IgM
(1:20,000; Jackson ImmunoResearch Laboratories, Inc.).
p38 and Erk-1/2 proteins expression was revealed with ECL
as per manufacturer’s instructions.
2.7. Assessment of Neutrophils Apoptosis by Cytology and
by Flow Cytometry. PMNs (100μLo fa1 0× 106 cells/mL
suspension in RPMI-1640 supplemented with 10% autol-
ogous serum) were incubated with or without CHE
(500μg/mL) for indicated times in the presence or absence
of caspase-1, -3, -4, and -7 inhibitor, N-benzyloxycarbonyl-
V-A-D-O-methyl-ﬂuoromethyl ketone (z-VAD-FMK), cas-
pase-3 inhibitor z-Asp(OMe)-Gln-Met-Asp(OMe)-FMK (z-
DQMD-FMK), irreversible caspase-6 inhibitor z-Val-Glu
(OMe)-Ile-Asp(OMe)-FMK (z-VEID-FMK), or irreversible
caspase-9 inhibitor z-Leu-Glu(OMe)-His-Asp(OMe)-FMK
(z-LEHD-FMK), or appropriate controls, as indicated in
the ﬁgure legends, and apoptosis was evaluated by cytol-
ogy and/or ﬂow cytometry. Cytocentrifuge preparations
of neutrophils were performed with a Cyto-tek centrifuge
(MilesScientiﬁc)essentiallyaspreviouslydescribedandwere
stained with a Diﬀ-Quick staining kit (Baxter Healthcare
Corporation, Miami, FL, USA), according to the manufac-
turer’s instructions. Cells were examined by light microscopy
at 400x ﬁnal magniﬁcation, and apoptotic neutrophils were
deﬁned as cells containing one or more characteristic darkly
stained pyknotic nuclei. An ocular containing a 10 ×
10-square grill was used to count at least ﬁve diﬀerent
ﬁelds (>100 cells) for assessment of apoptotic cells. Results
were expressed as percentage of apoptotic cells. For the
ﬂow cytometric procedure, apoptosis was investigated using
ﬂuorescence labelling with Annexin-V-FITC binding or anti-
CD16-FITC as previously published [22]. Ten thousand cells
wereanalyzedbyFACSCalibur(Becton-Dickinson, SanJose,
CA)usingCellQuestprogram(BDBiosciences,SaoJose,CA,
USA). The number of late apoptotic and necrotic cells was
subtracted in order to evaluate the percentage of apoptotic
cells.
2.8. Degradation of Cytoskeletal Proteins. Neutrophils (10
× 106 cells/mL in a 96-well plate) were incubated with
or without 1000ng/mL VAA-I or 500μg/mL CHE in its
diluent (1% DMSO) for the indicated time period and then
harvested for the preparation of cell lysates in Laemmli’s
sample buﬀer (Figure 5). Aliquots corresponding to 500,000
cells were loaded onto 10% SDS-PAGE and transferred from
gel to nitrocellulose membranes (Amersham Pharmacia Bio-
tech Inc, Baie d’Urf´ e, QC, Canada). Nonspeciﬁc sites were
blocked with 3% BSA in TBS-T for 1h at room temperature.
Membranes were incubated with monoclonal anti-human
cytoskeletal Abs (anti-gelsolin, anti-paxillin, anti-vimentin,
and anti-vinculin) in the dilution of 1:1000 for 1h at room
temperature, followed by 3 washes, and incubated with an
HRP-labelled goat anti-mouse IgG (1/15,000; BIO/CAN,
Montreal, Canada) for 1h at room temperature in fresh
blocking solution [23]. Membranes were washed three times
with TBS-T and bands were revealed with the ECL-Western
blottingdetectionsystem(PharmaciaBiotech).Proteinload-
ing was veriﬁed by staining the membranes with Coomassie
blue at the end of the experiments.
3. Results
3.1. CHE Is a Human Neutrophil Activator. Because this was
the ﬁrst time that CHE was tested in human PMNs, we
ﬁrst determined its potential cytotoxicity. To do so, freshly
isolated PMNs were incubated in vitro with increasing con-
centrations of CHE (0–1000μg/mL) over time (0–24h) and
necrosis was assessed by a trypan blue exclusion assay. Cell
necrosis never exceeded 3% at concentrations ≤500μg/mL,
and the number of cells initially seeded remained stable in
plates observed 24h later (data not shown). Cell necrosis
never exceeded 5% when cells were incubated with CHE at
concentrations greater than 500μg/mL for shorter periods
of time (less than 60min), but up to 15% of cells displayed4 Mediators of Inﬂammation
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Figure 1: CHE induces actin ﬁlament polymerization in human PMNs. Freshly isolated human neutrophils were isolated and incubated (10
× 106 cells/mL) with the diluent (HBSS-1% DMSO, Ctrl), crude hydroalcoholic extract (CHE) (500μg/mL), or fMLP (10−8M) for 5, 15,
or 30min. Actin polymerization was evaluated by monitoring FITC-phalloidin expression by ﬂow cytometry. (a) Results are means ± SEM
(n = 3). (b) Results shown are from one representative experiments plotted in (a). ∗P<0.05 (versus Ctrl) by Student’s t-test.
necrosis at the highest concentration tested (1000μg/mL)
after 24h of incubation (data not shown). Based on these
results, we selected the concentration of 500μg/mL for the
remainder of this study, unless otherwise speciﬁed. Next, we
determined whether or not CHE could induce actin poly-
merization, a typical assay for evaluating PMN activation
[24, 25]. As illustrated in Figure 1, CHE increased actin
polymerization, but this response required about 15min
to occur, as judged by the shift of ﬂuorescence following
phalloidin staining.
3.2. CHE Induces Phosphorylation Events: Activation of
p38 but Not ERK-1/2 MAPKs. The aforementioned results
strongly suggested that CHE could modulate PMN func-
tions. We next evaluated the possibility that CHE acti-
vated phosphorylation events, since this cell signaling is
important for modulating PMNs functions. As illustrated
in Figure 2(a), CHE rapidly activated PMNs, as judged by
increased signal intensity of total phosphotyrosine proteins
detected by western blot after 30 seconds, peaking at 15–
30minutes and then declining after 45min. Because p38 and
ERK-1/2 MAPKs play signiﬁcant roles in human PMN activ-
ity, we next determined whether or not CHE activated these
kinases. CHE was found to activate p38 (Figure 2(b))b u t
not ERK-1/2 (Figure 2(c)), despite the fact that, as expected,
the cytokine GM-CSF strongly induced phosphorylation of
ERK-1/2.
3.3. CHE: an Atypical Inducer of PMN Apoptosis. Several
assays were used to evaluate the eﬀect of CHE on PMN
apoptosis.Asassessedbycytology,CHEsigniﬁcantlyinduced
apoptosis at a concentration of ≥500μg/mL, where 79.0 ±
6.0% (mean ± SEM, n = 5) of cells were typically in
apoptosis (pyknotic nuclei) versus 50.3 ± 2.6% for controls
or SA (Figure 3(a)). We then evaluated apoptosis by ﬂow
cytometry with FITC-annexin-V, known to be increased
at the apoptotic cell surface. As expected, a greater num-
ber of PMNs were annexin-V-positive when treated with
500μg/mL CHE versus SA (97.8% ± 0.9 versus 56.1% ± 5.6
for SA) (Figure 3(b)). In contrast to annexin-V, CD16 is
known to be shed from the cell surface of apoptotic PMNs,Mediators of Inﬂammation 5
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Figure 2: CHE induces tyrosine phosphorylation events in human
neutrophils. (a), Freshly PMNs were isolated and incubated (10 ×
106 cells/mL)withthediluent(HBSS-1%DMSO,Ctrl),granulocyte
macrophage colony-stimulating factor (GM) (65ng/mL) (lane 2),
and crude hydroalcoholic extract (CHE)(500μg/mL) at the periods
of stimulation of 0.5, 1, 5, 15, 30, 45, or 60min. Immunoblotting
was performed as described in Section 2. Top panel: tyrosine
phosphorylationofintracellularproteins;bottompanel,Coomassie
blue staining of the membrane to indicate equivalence in loading.
(b) and (c) cells were stimulated for 10min with the diluent
( C t r l ) ,G M - C S F( G M ,6 5 n g / m L ) ,o rw i t hC H E( 5 0 0 μg/mL) for
5, 15 or 30min. Immunoblotting was performed as described in
Section 2.(b)and(c)Toppanelsillustratethemembranesthatwere
revealed with antiphosphorylated p38 (b) or antiphosphorylated
ERK-1/2 (c) antibodies; bottom panels are the corresponding
membranestainedwiththeunphosphorylatedformofp38orERK-
1/2, respectively, indicating equivalent loading. Results shown are
representative of at least three diﬀerent experiments.
leading to a decrease in expression [26]. Unexpectedly, we
found that CD16 levels were not signiﬁcantly decreased
in CHE-induced PMNs (data not shown). We then con-
ducted a series of experiments in which apoptosis was
evaluated in parallel using cytology and ﬂow cytometry, to
monitoring CD16 cell surface expression in apoptotic cells.
As expected, VAA-I, a potent pro-apoptotic plant lectin,
induced apoptosis as assessed by cytology (Figure 4(a))a n d
decreased the cell surface expression of CD16 (Figure 4(b))
as compared to SA, whereas CHE induced apoptosis as
determined by cytology, but levels of cell surface expression
of CD16 did not signiﬁcantly decrease in PMNs isolated
from the same blood donors as compared to SA. Since
these latter results suggested that CHE induced atypical
PMN apoptosis, we then investigated the degradation of
cytoskeletal proteins, an event characteristic of apoptosis. As
shown in Figure 5, CHE induced the degradation of gelsolin
as evidenced by the appearance of the 41kDa fragment [19]
and the degradation of the two main 60 and 48kDa paxillin
polypeptides recognized by the antibody [27]. These results
were not surprising, since CHE is a pro-apoptotic molecule.
Unexpectedly, CHE did not induce the degradation of the
intermediate ﬁlament protein vimentin, despite the fact that,
as expected, the pro-apoptotic VAA-I molecule induced its
cleavage [27].
3.4. Involvement of Caspases in CHE-Induced PMN Apoptosis.
Since CHE induced the cleavage of gelsolin and paxillin, an
event requiring caspase activation [19, 27], we next decided
to investigate whether or not CHE acted via caspases. CHE-
induced PMNs were incubated in the presence or absence
of a pan-caspase inhibitor (z-VAD-fmk) or a caspase-3 (z-
DQMD-FMK), caspase-6 (z-VEID-FMK), or caspase-9 (z-
LEHD-FMK)-speciﬁc inhibitor and apoptosis was evaluated
bycytology. As expected, thetested inhibitors suppressed SA,
butonlythepancaspaseinhibitorwasabletoreversethepro-
apoptotic activity of CHE when the apoptotic rate was 70%
rather than close to 90% (grey zone in Figure 6). All other
inhibitors did not signiﬁcantly reverse the ability of CHE to
induce apoptosis.
3.5. CHE Induced Apoptosis by a p38-Independent Mech-
anism. We then decided to determine whether or not
p38 was involved in CHE-induced neutrophil apoptosis,
since this kinase is activated by CHE. However, as illus-
trated in Figure 7, treatment with the p38-speciﬁc inhibitor
(SB203580) did not reverse the pro-apoptotic activity of
CHE, despite the fact that this inhibitor, as well as the MEK-
1/MEK-2 inhibitor, was able to reverse the antiapoptotic
activity of the cytokine GM-CSF.
4. Discussion
During apoptosis, PMNs are known to shrink and cytoskele-
ton breakdown occurs, as has been shown by the cleavage of
several cytoskeletal proteins largely associated with caspase
activity [19, 27–29]. Because of the importance of elimi-
nating apoptotic PMNs by professional phagocytes for the
resolution of inﬂammation [13, 14, 16, 18, 30], it is critical
to identify new agents that may act as neutrophil activators
and, more speciﬁcally, that may act as regulators of PMN
apoptosis, and to understand their modes of action.
This is the ﬁrst study to investigate the role of the
CHE from Esenbeckia leiocarpa bark in human neutrophil
cell physiology, an extract that possesses interesting anti-
inﬂammatory properties [31]. Clearly, CHE is a novel PMN6 Mediators of Inﬂammation
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Figure 3:CHEinducesapoptosisinhumanneutrophils.Freshlyisolatedhumanneutrophilswereisolatedandincubated(10 ×106 cells/mL)
with the diluent (SA) or with the indicated concentrations of CHE for 22h. Apoptosis was evaluated by cytology (a) or by ﬂow cytometry
(b) using FITC-annexin-V as described Section 2. Inset in (a): picture of apoptotic (asterisks) or nonapoptotic (arrows) PMNs. Inset in (b):
typical results obtained by FACS analysis from one experiments plotted in the corresponding bar graph. Results are means ± SEM (n ≥ 3).
SA: spontaneous apoptosis (cells incubated with the diluent). ∗P<0.05 versus SA by Student’s t-test.
activator, since it induced actin polymerization and cell
signaling events, including p38 activation. Furthermore,
CHE induced cleavage of cytoskeletal proteins and PMN
apoptosis. The fact that the pro-apoptotic activity of CHE
was reversed by the z-VAD-FMK pan-caspase inhibitor
(known to inhibit the eﬀector caspase-1, -3, -4, and -7)
suggests that several caspases could be simultaneously or
sequentially activated and also that several pathways of cell
apoptosis may be involved. Caspase-3 is known to be a
central player in both classical extrinsic and intrinsic path-
ways of cell apoptosis [32]. In addition, caspase-4 activation
is known to be a major event occurring during the more
recentlyidentiﬁedpathwayofcellapoptosis:theendoplasmic
reticulum (ER) stress-induced apoptosis. Only recently have
there been some evidences of the ER stress-induced pathway
in human PMNs [33]. In contrast to z-VAD-FMK, the more
speciﬁc inhibitors used in this study (those to caspase-3,
-6, or -9) were not able to reverse the CHE pro-apoptotic
activity. Because CHE accelerated SA, and the three main
pathways of cell apoptosis were activated during SA, it
is plausible that inhibiting only one caspase with a more
speciﬁc inhibitor than the pancaspase was not suﬃcient to
reverse the eﬀect of CHE. In addition, CHE is a crude extract
composed of several hundred chemical compounds; because
of this, it is plausible that some compounds preferentially
activate a given cell apoptotic pathway, while others activate
several pathways leading to the inability of a particular
caspase inhibitor to reverse the pro-apoptotic activity of
CHE.However,thefactthattreatmentwiththep38inhibitor
(SB203580) did not reverse the pro-apoptotic activity of
CHE led us to conclude that CHE induced PMN apoptosis
by a p38-independent mechanism, and that p38 is probably
involved in other PMN functions, although this remains to
be determined. Several MAPKs, including p38 and ERK-
1/2, are known to be involved in the regulation of PMN
apoptosis [32]. ERK-1/2 activation is normally implicated inMediators of Inﬂammation 7
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Figure 4: The pro-apoptotic activity of CHE does not correlate with CD16 shedding. Cells (10 × 106 cells/mL) were incubated with the
diluent (SA), 1000ng/mL Viscum album agglutinin-I (VAA), or 500μg/mL CHE for 22h and apoptosis was evaluated in parallel for each
blood donors by cytology (a) or by monitoring CD16 cell surface expression by ﬂow cytometry (b). Inset in (b): typical results obtained by
FACS analysis and plotted in the corresponding bar graph. Results are means ± SEM (n = 4). ∗P<0.05 versus SA by Student’s t-test.
PMN survival, while activation of p38 is observed in PMNs
in response to treatment with pro- or antiapoptotic agents.
Thus, the role of p38 in the regulation of PMN apoptosis is
unclear and the present data support further our hypothesis
that p38 is involved in functions other than apoptosis in
human PMNs.
The mode of action of CHE for inducing apoptosis is
not a conventional one. In general, pro-apoptotic agents
increase CD16 shedding in human PMNs [26], but CHE
did not alter CD16 cell surface expression when compared
to SA. However, CHE increased cell surface expression of
annexin-V and induced typical morphological changes, as
evidenced by the appearance of pyknotic nuclei. Although
the mechanism involved in CD16 shedding is not fully
deﬁned, it appears that a metalloproteinase is responsible
for CD16 shedding [34, 35]. Of note, it has been reported
previously that CD16 shedding is not only inhibited by
metalloproteinase inhibitors, but also by serine protease
inhibitors indicating inhibited that this phenomenon is very
complex [35, 36]. Furthermore, a link between cytoskeleton
rearrangement and the induction of CD16 shedding has
been proposed, and actin polymerization has been found to
inducesheddingofCD16[24].Thiswasdeterminedwiththe
use of jasplakinolide, an actin-polymerizing peptide, where
enhanced actin polymerization was found to induce time-
and concentration-dependent shedding of CD16. Therefore,8 Mediators of Inﬂammation
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Figure 7: CHE induces apoptosis in a p38-independent mecha-
nism. Cells (10 × 106 cells/mL) were incubated with (+) or without
(−) CHE or the antiapoptotic cytokine GM-CSF (GM, 65ng/mL)
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the fact that CHE did not increase CD16 shedding but
induced actin polymerization is another criterion indicating
that CHE induces atypical apoptosis in PMNs. In addition,
although CHE induced the degradation of the cytoskeletal
proteins gelsolin and paxillin, as expected for pro-apoptotic
molecules, it did not induce the degradation of vimentinMediators of Inﬂammation 9
that is normally increased by pro-apoptotic agents when
compared to SA [23, 27].
In conclusion, the results of this study clearly establish
that CHE is a novel PMN activator. Although its mode of
action has not yet been fully deﬁned, we demonstrated that
CHE induced tyrosine phosphorylation events, including
p38 activation, and targeted the cytoskeleton, as evidenced
by actin polymerization and degradation of cytoskeletal
proteins. CHE induces apoptosis in PMNs by a caspase-
dependent and p38-independent mechanism but acted as an
atypicalpro-apoptoticagent,basedonitsinabilitytoincrease
CD16 shedding and vimentin degradation. It is not without
any precedent that a proapoptotic agent induces apoptotis
in human PMNs, since we have previously demonstrated
that arsenic trioxide also activates p38, but not ERK [37].
We conclude that CHE possesses in vitro anti-inﬂammatory
properties,basedonitsabilitytoinducePMNapoptosis, and
this may be, at least in part, responsible for its previously
reported in vivo anti-inﬂammatory activity.
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